tripelennamine has been researched along with Rheumatic Diseases in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roscioni, C | 1 |
| De Ritis, G | 1 |
| Lotti, A | 1 |
| Pozzessere, C | 1 |
| De Rossi, P | 1 |
| Granato, C | 1 |
| Bruno, VF | 1 |
| Nola, P | 1 |
| Morabito, F | 1 |
| De Tommaso, G | 1 |
1 trial available for tripelennamine and Rheumatic Diseases
| Article | Year |
|---|---|
[Analgesic, antipyretic and anti-rheumatic activity of 2 preparations evaluated in a multicenter clinical trial].
Topics: Acetaminophen; Adolescent; Adult; Aged; Aspirin; Caffeine; Child; Child, Preschool; Clinical Trials | 1982 |